Sign in

CIK 0001359931 · Non-accelerated filer<br>Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
204580525
Phone
646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. SC 13G/A Stake Amended Statement of Ownership
  2. 4 Insider Changes in Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 8-K Event Executive or director change · Other events
  5. 424B3 Offering Prospectus
  6. EFFECT Other Notice of Effectiveness
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  10. S-3 Offering Registration Statement
  11. SC 13D/A Stake Beneficial Ownership Report
  12. SC 13D Stake Beneficial Ownership Report
  13. SC 13D/A Stake Beneficial Ownership Report
  14. SC 13D/A Stake Beneficial Ownership Report
  15. SC 13G Stake Amended Statement of Ownership
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 4 Insider Changes in Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 4 Insider Changes in Ownership
  20. 3 Insider Initial Statement of Ownership

Page 22 of 41 · 811 filings